On the Move - Company Changes (12/2005)
BENICK, Frank D.
To: Mediscience Technology Corp., CFO(Nov.)
From: Cust, Dori & Benick, P.A., Partner
Tel: 215-485-0362
BUSENBARK, Gordon H.
To: Encysive Pharmaceuticals Inc., CFO(Oct.)
From: Baxter Healthcare Corp., VP, Global Quality
Tel: 713-796-8822
CHRISTIAN, Todd P.
To: Guava Technologies Inc., VP, Commercial Oper.(Nov.)
From: Applied Biosystems Inc., General Mgr., Cell Biology
Tel: 510-576-1400
CLARKE, Kevin P.
To: Kos Pharmaceuticals Inc., EVP, CFO(Nov.)
From: Bear, Stearns & Co. Inc., Sr. Managing Dir., Healthcare M&A
Tel: 609-495-0500
COLE, George W.
To: Encysive Pharmaceuticals Inc., COO(Nov.)
From: Altana Pharma US, Pres., Brand & Generic Businesses
Tel: 713-796-8822
COLES, N. Anthony, MD
To: NPS Pharmaceuticals Inc., Pres. & COO(Nov.)
From: Vertex Pharmaceuticals Inc., SVP, Commercial Oper.
Tel: 801-583-4939
DANNER, John P.
To: Codon Devices, Pres. & CEO(Nov.)
From: PerkinElmer Inc., VP & General Mgr., Biopharmaceutical Business Group
Tel: 617-995-7999
DARLING, Joseph G.
To: Smith & Nephew Endoscopy, VP, Mktg.(Oct.)
From: Baxter International Inc., VP, Mktg., Medication Delivery Systems
Tel: 978-749-1000
DAVID, Zvi Ben
To: UltraShape Ltd., CFO(Nov.)
From: Given Imaging Ltd., Corp. VP, CFO
Tel: 972-3-645-7100
DAY, Wesley W., PhD
To: Vivus Inc., VP, Clinical Dev.(Nov.)
From: Pfizer Inc., Sr. Dir., Therapeutic Area Head, Oncology & Opthalmology
Tel: 650-934-5200
DHIR, Lalit
To: Guava Technologies Inc., VP, Corp. Dev. & Strategic Mktg.(Nov.)
From: BD Biosciences, VP, Bus. Dev.
Tel: 510-576-1400
DUDLEY, Mike
To: Mpex Pharmaceuticals Inc., VP, Drug Dev.(Nov.)
From: Diversa Corp., VP, Preclinical & Clinical Sciences
Tel: 858-875-2840
EGBERTS, Jan H., MD
To: NovaDel Pharma Inc., COO(Dec.)
From: Dynogen Pharmaceuticals Inc., COO
Tel: 908-782-3431
ELLISON, Russell H., MD
To: FibroGen Inc., VP, Clinical Dev.(Nov.)
From: Sanofi-Synthelabo, VP, Medical Affairs & CMO
Tel: 650-866-7200
ESTOK, Thomas M.
To: Conforma Therapeutics Corp., Chief Commercial Officer(Oct.)
From: Schering-Plough Corp., VP, US Mktg. & Commercial Dev., Oncology Franchise
Tel: 858-657-0300
FANNING, Todd
To: Cortek Inc., Pres.(Nov.)
From: Abbott Spine, VP, Sales & Mktg.
Tel: 781-407-0020
GORBACH, Sherwood L., MD
To: Optimer Pharmaceuticals Inc., SVP, Medical Affairs & CMO & Prof., Community Health & Medicine, Tufts University School of Medicine(Oct.)
From: Tufts University School of Medicine, Prof., Community Health & Medicine
Tel: 858-909-0736
HENKEL, Timothy, MD, PhD
To: PolyMedix Inc., VP, Drug Dev. & CMO(Nov.)
From: Vicuron Pharmaceuticals Inc., EVP, CMO
Tel: 215-966-6199
HORTON, Kenneth L.
To: MDS Inc., EVP, Corp. Dev.(Nov.)
From: PerkinElmer Inc., VP, Acquisitions, Ventures & General Counsel, Life & Analytical Sciences Bus. Unit
Tel: 416-675-7661
JAPP, Christopher N.
To: Del Medical Systems, Pres.(Nov.)
From: St. Jude Medical International, VP, Cardiac Surgery
Tel: 847-288-7000
JETER, James E.
To: MedicalCV Inc., VP, Sales(Nov.)
From: Medtronic Inc., Central States Regional Mgr.
Tel: 651-452-3000
JIWANI, Mahedi
To: Uroplasty Inc., VP, CFO(Nov.)
From: M.A. Gedney Company, CFO
Tel: 612-378-1180
Executive Recruiter: CPR International Inc.
KELLOGG, Rodney
To: DexCom Inc., VP, Sales(Nov.)
From: Smiths Medical, VP & GM, Diabetes Div.
Tel: 858-200-0200
KNAPP, Jeffrey
To: Abgenix Inc., SVP, Sales & Mktg.(Nov.)
From: Pharmion Corp., VP, Sales & Mktg.
Tel: 510-608-6500
LUCAS, Virgil Sol
To: Serenex Inc., VP, Clinical Dev.(Nov.)
From: GlaxoSmithKline PLC, Sr. Therapeutic Area Dir., Oncology, Clinical Pharmacology, Discovery Medicine
Tel: 919-281-6001
MANGASARIAN, Aram
To: Novexel, VP, Bus. Dev.(Nov.)
From: ExonHit Therapeutics SA, VP, Bus. Dev.
Tel: 33-1-5714-0777
MASI, Dina L.
To: Integrated BioPharma Inc., SVP, CFO(Nov.)
From: Consultant
Tel: 973-926-0816
MULROY, Dennis M.
To: Cardium Therapeutics Inc., CFO(Nov.)
From: Molecular Imaging Corp., CFO
Tel: 858-436-1000
ORLEMANS, Everardus, PhD
To: Pozen Inc., VP, Clinical Research(Nov.)
From: Organon USA Inc., Exec. Dir., Clinical Dev.
Tel: 919-913-1030
PEREIRA, Brian J. G., MD
To: Advanced Magnetics Inc., Pres.(Nov.)
From: Tufts New England Medical Center, Pres. & CEO & Professor of Medicine, Tufts University
Tel: 617-497-2070
PIPER, J. Kris
To: Xanthus Life Sciences Inc., VP, Reg. Affairs & Quality Assurance(Nov.)
From: Bracco SPA, VP, Global Preclinical & Clinical Reg. Affairs
Tel: 617-225-0522
RUBINO, Alan L.
To: Pharmos Corp., Pres. & COO(Nov.)
From: Hoffmann-La Roche Inc., SVP
Tel: 732-452-9556
SCHMALBACH, Tess, MD, PhD
To: Dyax Corp., SVP, Clinical & Medical Affairs & CMO(Nov.)
From: Coley Pharmaceuticals Group, VP, Clinical Dev.
Tel: 617-225-2500
SPINELLA, Jennifer A.
To: Cardium Therapeutics Inc., VP, Reg. Affairs(Nov.)
From: Biogen Idec Inc., Dir., Reg. Affairs
Tel: 858-436-1000
VAN TASSEL, Jason R., MD
To: LifeStem Inc., CMO(Nov.)
From: Pacific Specialists, ENT Specialist & Cosmetic Surgery
Tel: 949-450-9398
ZHENG, Qun Yi, PhD
To: Cortech Inc., Pres.(Nov.)
From: Pure World Inc., Pres.
Tel: 908-234-1881
a1>